Greater Metropolitan NYC and Long Island
JACKSONVILLE, Fla., Oct. 11 /PRNewswire-FirstCall/ -- An affiliate of Phlo Corporation (OTC: PHLC) (the "Company") announced today that it will launch its vitality beverage product, AQUISS(TM), on the East Coast in November.
AQUISS(TM) initially will be distributed in the greater metropolitan New York City area, including Manhattan, Brooklyn, Queens, the Bronx, and Long Island. Aquiss(TM) will be launched in all channels of distribution, including chain grocers, chain convenience stores, chain drug stores, independent grocers, independent convenience stores, and mass merchandisers.
"Our East Coast launch will provide us with tremendous coverage in one of the most populated and valuable pieces of the world -- the impact on corporate value should be significant, as coverage in this region provides in most every field," said James B. Hovis, CEO of the Company.
AQUISS(TM) features the Company's Instant Nano Hydration and Cell Armor technologies, providing instant, direct delivery of rehydration and cell- repair-and-protection payloads into the bloodstream beginning through the membranes of the mouth. These Instant Nano Hydration and Cell Armor technologies help provide sustained wellness necessary for life's performances and vigorous longevity. In addition, the Company's nano-encapsulation technology prevents the destruction of its active payloads in the stomach.
Phlo is a biotechnology company and a manufacturer and marketer of products (primarily liquids) containing patented and patent-pending biotechnologies. Phlo is focusing its technology generation and acquisition efforts on those technologies related to enhancing cognition and personal performance, reducing the effects of aging, and preventing or ameliorating cancer.
Certain statements made herein that are not historical constitute
"forward-looking" statements within the meaning of the Private Litigation
|SOURCE Phlo Corporation|
Copyright©2007 PR Newswire.
All rights reserved